← All trials
NCT07075718
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 12, 2025
- Primary completion
- Mar 31, 2028
- Completion date
- Mar 31, 2032
- First posted
- Jul 20, 2025
- Last posted
- Jul 22, 2025
- Enrollment
- 610
- Arms / groups
- 9 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Glaukos CorporationLead sponsor
- Glaukos CorporationOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.